TR201618030T2 - Tastedly corrected paracetamol formulations. - Google Patents

Tastedly corrected paracetamol formulations.

Info

Publication number
TR201618030T2
TR201618030T2 TR2016/18030T TR201618030T TR201618030T2 TR 201618030 T2 TR201618030 T2 TR 201618030T2 TR 2016/18030 T TR2016/18030 T TR 2016/18030T TR 201618030 T TR201618030 T TR 201618030T TR 201618030 T2 TR201618030 T2 TR 201618030T2
Authority
TR
Turkey
Prior art keywords
tastedly
corrected
paracetamol
paracetamol formulations
formulations
Prior art date
Application number
TR2016/18030T
Other languages
Turkish (tr)
Inventor
Gi̇deroz Tuba
Kandemi̇rer Ürün
Odabaşi Serap
Original Assignee
Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201618030T2 publication Critical patent/TR201618030T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Abstract

Bu buluş, acı tada sahip parasetamol etkin maddesini içeren fannasötik formülasyonların tadının metal tuzlan kullanılarak iyileştirilmesi ile ilgilidir.The present invention relates to improving the taste of pharmaceutical formulations containing the bitter taste paracetamol active agent using metal salts.

TR2016/18030T 2014-08-14 2015-08-13 Tastedly corrected paracetamol formulations. TR201618030T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201409474 2014-08-14
PCT/TR2015/000305 WO2016024928A1 (en) 2014-08-14 2015-08-13 Taste masked paracetamol formulations

Publications (1)

Publication Number Publication Date
TR201618030T2 true TR201618030T2 (en) 2018-09-21

Family

ID=54065431

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/18030T TR201618030T2 (en) 2014-08-14 2015-08-13 Tastedly corrected paracetamol formulations.

Country Status (2)

Country Link
TR (1) TR201618030T2 (en)
WO (1) WO2016024928A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11202756B2 (en) 2018-04-18 2021-12-21 Shilpa Medicare Limited Oral disintegrating film compositions of paracetamol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
AU7176994A (en) 1993-06-25 1995-01-17 Ibah, Inc. Taste-masked acetaminophen suspensions and methods of making the same
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
EP1581197A1 (en) 2002-12-11 2005-10-05 Ranbaxy Laboratories, Limited Coating composition for taste masking coating and methods for their application and use
WO2004087111A1 (en) 2003-04-04 2004-10-14 Ranbaxy Laboratories Limited Oral taste masked pharmaceutical compositions
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
WO2013175511A1 (en) * 2012-05-24 2013-11-28 V.B. Medicare Pvt. Ltd. Taste masked pharmaceutical compositions

Also Published As

Publication number Publication date
WO2016024928A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
AU2024202345A1 (en) Nucleic acid carriers and therapeutic methods of use
ECSP17016797A (en) INDAZOLES SUBSTITUTED WITH BENZYL AS BUB1 INHIBITORS
MY195681A (en) Aqueous Pharmaceutical Formulation Comprising Anti-Pd-L1 Antibody Avelumab
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA033163B1 (en) Inhibitors of glutaminase
BR112017013491A2 (en) fused pyrimidine compounds for the treatment of hiv
BR112016021012A2 (en) pharmaceutical compositions of therapeutically active compounds.
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
EA201791454A1 (en) DRUG FORMS FOR TRANSDERMAL ADMINISTRATION
EA201790847A1 (en) COMPOSITIONS AND METHODS OF TREATMENT WITH THE USE OF TIZOXANIDE PROCEDURES, ITS ANALOGUE OR SALT
EA201790650A1 (en) DOSAGE FORM AND METHODS OF APPLICATION OF ABIRATERONE ACETATE
BR112017028549A2 (en) pyrimidine derivatives as btk inhibitors and uses thereof
EA201791992A1 (en) GRELIN-O-ACYLTRANSFERASE INHIBITORS
MY186047A (en) Eutectic formulations of cyclobenzaprine hydrochloride
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
BR112017009289A2 (en) methods of administering amantadine compositions
EA201792000A1 (en) GRELIN-O-ACYLTRANSFERASE INHIBITORS
EA201791600A1 (en) DERIVATIVES OF HYDROXIALKILPIPERASINE AS RECESSOR CXCR3 MODULATORS
EA201500821A1 (en) Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds
EA201792262A1 (en) PIROGLUTAMAT VORTIOKSETINA
CY1122473T1 (en) HIGH DOSE OPTIMIZED MID-SALIZED TABLET
IN2014CH00840A (en)
EA201591717A1 (en) Solid Forms of Vumurafenib Hydrochloride